Cytokinetics, Incorporated (CYTK) DCF Valuation

Cytokinetics, Incorporated (CYTK) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

Cytokinetics, Incorporated (CYTK) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Designed for accuracy, our Cytokinetics DCF Calculator helps you evaluate Cytokinetics, Incorporated (CYTK) valuation using real-world financial data while offering complete flexibility to modify all key parameters for improved projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 26.9 55.8 70.4 94.6 7.5 8.8 10.3 12.1 14.2 16.6
Revenue Growth, % 0 107.79 26.15 34.3 -92.04 17.1 17.1 17.1 17.1 17.1
EBITDA -93.0 -86.8 -176.3 -329.4 -456.7 -8.8 -10.3 -12.1 -14.2 -16.6
EBITDA, % -346.28 -155.45 -250.39 -348.25 -6064.86 -100 -100 -100 -100 -100
Depreciation 1.3 1.8 9.6 8.4 11.9 2.3 2.7 3.2 3.7 4.3
Depreciation, % 4.81 3.28 13.68 8.88 157.93 26.13 26.13 26.13 26.13 26.13
EBIT -94.3 -88.6 -186.0 -337.8 -468.6 -8.8 -10.3 -12.1 -14.2 -16.6
EBIT, % -351.09 -158.73 -264.07 -357.13 -6222.79 -100 -100 -100 -100 -100
Total Cash 225.1 464.1 471.6 782.6 614.8 8.8 10.3 12.1 14.2 16.6
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 5.2 4.4 51.8 .1 1.3
Account Receivables, % 19.22 7.92 73.58 0.15541 17.04
Inventories .0 -4.4 -51.8 -.1 .0 -1.4 -1.7 -2.0 -2.3 -2.7
Inventories, % 0 -7.92 -73.58 -0.15541 0 -16.33 -16.33 -16.33 -16.33 -16.33
Accounts Payable 8.2 8.1 21.1 25.6 21.5 3.6 4.2 4.9 5.7 6.7
Accounts Payable, % 30.37 14.42 29.94 27.08 285.62 40.36 40.36 40.36 40.36 40.36
Capital Expenditure -2.6 -11.1 -48.9 -11.3 -1.4 -2.3 -2.7 -3.1 -3.7 -4.3
Capital Expenditure, % -9.75 -19.8 -69.39 -11.98 -18.8 -25.95 -25.95 -25.95 -25.95 -25.95
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -115.5 -114.3 -209.4 -349.6 -468.6 -8.8 -10.3 -12.1 -14.2 -16.6
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -113.9 -118.4 -235.6 -348.0 -463.5 -26.1 -9.8 -11.5 -13.4 -15.8
WACC, % 8.07 8.07 8.07 8.07 8.07 8.07 8.07 8.07 8.07 8.07
PV UFCF
SUM PV UFCF -62.2
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -16
Terminal Value -265
Present Terminal Value -179
Enterprise Value -242
Net Debt 643
Equity Value -884
Diluted Shares Outstanding, MM 97
Equity Value Per Share -9.16

What You Will Get

  • Real CYTK Financial Data: Pre-filled with Cytokinetics' historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See Cytokinetics' intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Customizable Clinical Trial Parameters: Adjust essential inputs such as patient enrollment rates, treatment efficacy, and study duration.
  • Real-Time Data Analysis: Provides instant insights into trial results, statistical significance, and other key metrics.
  • High-Precision Forecasting: Utilizes Cytokinetics' real-world data for accurate projections and outcomes.
  • Effortless Scenario Simulation: Easily evaluate various clinical scenarios and their potential impacts on results.
  • Efficiency Booster: Streamline the process by avoiding the complexities of building trial models from the ground up.

How It Works

  1. Step 1: Download the Excel file for Cytokinetics, Incorporated (CYTK).
  2. Step 2: Review the pre-filled financial data and forecasts specific to Cytokinetics.
  3. Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Observe the DCF model refresh in real-time as you modify your assumptions.
  5. Step 5: Evaluate the results and apply them to your investment strategies.

Why Choose This Calculator for Cytokinetics, Incorporated (CYTK)?

  • Designed for Experts: A sophisticated tool utilized by researchers, financial analysts, and investment advisors.
  • Accurate Data: Cytokinetics’ historical and projected financials are preloaded for precision.
  • Flexible Scenario Analysis: Effortlessly test various forecasts and assumptions.
  • Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
  • User-Friendly: Step-by-step guidance ensures a smooth experience.

Who Should Use Cytokinetics, Incorporated (CYTK) Products?

  • Healthcare Investors: Make informed investment choices with cutting-edge pharmaceutical insights.
  • Clinical Researchers: Streamline your research with access to comprehensive data on drug efficacy.
  • Pharmaceutical Consultants: Quickly tailor presentations or reports for clients in the biotech sector.
  • Biotech Enthusiasts: Enhance your knowledge of drug development processes through real-life case studies.
  • Educators and Students: Utilize it as a hands-on resource in life sciences and pharmaceutical courses.

What the Template Contains

  • Pre-Filled DCF Model: Cytokinetics’ financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate Cytokinetics’ profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.

No products were found matching.